Not all people with CLL need therapy. In spite of all recent improvements, the iwCLL however recommends watchful observation for people with asymptomatic condition.86 This recommendation relies on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both equally trials concluded https://josueqmgas.liberty-blog.com/32572049/a-secret-weapon-for-link-alternatif-mbl77